Cbd

FDA tackles safety challenges related to ‘misinformation’ about CBD, food additives and how it makes science-based decisions

19-Feb-2024 By Elizabeth Crawford

Even as FDA stands by its decision that CBD is not safe for use in foods, beverages and dietary supplements, the agency is considering how best to ensure it is clearly labeled, safely manufactured and consumers understand what it is, according to a senior...

Rugby stars migrate from CBD to mushroom innovation

05-Jan-2024 By Nikki Hancocks

An athlete-founded supplement brand initially built around CBD has migrated into mycology as the team looks to create ways to remain innovative and relevant in the midst of an increasingly ‘frustrating’ regulatory landscape.

Why the FDA reorg is the biggest story of the year

21-Dec-2023 By Danielle Masterson

UNPA’s Israelsen breaks down the FDA’s restructuring and issues a call to action for the future of the industry.

Editors’ picks: Our favorite articles of 2023

14-Dec-2023 By The NutraIngredients-USA Team

We enjoy writing some articles more than others, whether it’s because of the subject, the impact for industry, the insights from commentators, or other reasons. But which articles did we enjoy writing the most and why?

CBD industry faces ‘existential crisis’

09-Nov-2023 By Claudia Adrien

Bethany Gomez, managing director of the Brightfield Group, spoke with NutraIngredients-USA about the difficulties the cannabidiol industry is experiencing when it comes to defining itself.

An 'historic' moment for CBD industry as UK Gov accepts recommended THC limit

24-Oct-2023 By Nikki Hancocks

The UK Government has accepted a recommended legal THC limit for CBD products in an ‘historic’ move that aims to bring some legal clarity to the industry, but an expert warns there are muddy waters yet to be cleared.

UK food law consultant: Don’t acquiesce to FSA’s new CBD dose opinion

23-Oct-2023 By Stephen Daniells

CBD industry stakeholders should not accept the UK Food Standards Agency’s recent downgrading of the CBD Acceptable Daily Intake (ADI), with recent studies advancing our understanding and potentially opening up opportunities to push for higher levels.

Holland & Barrett pulls 31 CBD products from shelves in response to FSA guidance

13-Oct-2023 By Nikki Hancocks

Holland & Barrett has temporarily removed 31 CBD products from shelves after new guidance from UK Food Standards Agency (FSA) which slashed recommended daily recommendations, leading industry to pull together to fight for survival.

Hemp Beverage Alliance sets out to help the category reach its potential

27-Sep-2023 By Rachel Arthur

Regulatory confusion and poor availability is hampering the success of hemp beverages in the US. But the consumer demand is clearly there, says the newly formed Hemp Beverage Alliance - which believes that, if these challenges are addressed, the category...

Bipartisan support for cannabidiol puts FDA, CBD coalitions in spotlight

26-Sep-2023 By Claudia Adrien

Advocates say there’s momentum in Congress to offer regulatory guidance for CBD supplement use.

Across generations, cannabinoids aid in physical recovery from exercise, survey finds

22-Sep-2023 By Claudia Adrien

CBD and/or THC users between 18-68 years old who avidly participate and are trained in aerobic and resistance exercise report the compounds aid in their physical recuperation, a new survey determined.

Charlotte’s Web-Canopy Growth analysis identifies safe CBD intake levels for supplements

18-Sep-2023 By Claudia Adrien

Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.

‘The risk we have here is enough to manage’: Athlete turned entrepreneur Floyd Landis discusses how regulatory uncertainty threatens the global CBD industry

15-Sep-2023 By Oliver Morrison

Regulatory bottlenecks are threatening to hinder CBD innovation on both sides of the Atlantic, the former professional road racing cyclist Floyd Landis tells FoodNavigator.

Top CBD companies’ lackluster sales, profits point to years-long national trend

08-Sep-2023 By Claudia Adrien

The US cannabidiol industry has seen a year-over-year decline in sales, despite attempts to bolster the CBD market with newer products.

CBD and botanical blend offers synergistic benefits for sleep and anxiety

30-Aug-2023 By Nikki Hancocks

A supplement containing CBD, CBN, GABA, hops oil, valerian oil, and low amounts of THC, reduced sleep disturbance, anxiety, stress, and improved well-being in a newly published RCT.

cbdMD CSO: ‘It appears that we’re finally making headway in Congress’

22-Aug-2023 By Stephen Daniells

The recent congressional hearing about CBD and subsequent ‘historic’ bicameral Request for Information (RFI) shows that hemp-derived CBD for use in dietary supplements has finally got the attention of Congress, said cbdMD’s CSO.

AHPA’s McGuffin: We oppose the reorganization of FDA’s food and supplements program

17-Jul-2023 By Stephen Daniells

The Board of the American Herbal Products Association will oppose FDA proposals to reorganize its dietary supplements program into a new Office of Food Chemical Safety, Dietary Supplements, and Innovation.

UNPA’s Israelsen: ‘Dietary supplements are not food additives - full stop’

10-Jul-2023 By Stephen Daniells

FDA’s recent proposal to relocate the Office of Dietary Supplement Programs (ODSP) to a new Office of Food Chemical Safety, Dietary Supplements, and Innovation, is disturbing, says UNPA’s Loren Israelsen.

HSA, FSA for supplements: ‘We are about to get the legislation introduced,’ says CRN’s Mister

05-Jul-2023 By Stephen Daniells

The ability for consumers to use pre-tax dollars for healthcare related expenses to purchase dietary supplements may be edging closer as legislation is about to be introduced in Congress to expand eligibility of dietary supplements in HSA and FSA accounts.

CBD alliance to benefit from AI technology

29-Jun-2023 By Olivia Haslam

The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have formed a strategic partnership with Chem ID Ltd, a provider of chemical data standardisation, validation, and traceability solutions.

Study explores CBD (non)effects on health-related fitness

21-Jun-2023 By Asia Sherman

Sports nutritionists at the University of Northern Colorado are investigating the influence of CBD consumption in physically active adults to resolve incongruities in the data surrounding its effects.

First-of-its-kind clinical trial supports CBD’s efficacy to boost sleep quality

13-Jun-2023 By Stephen Daniells

Four weeks of CBD (cannabidiol) supplementation at 15 mg per day led to clinically important improvement in their sleep quality, performing to a similar level to 5mg as melatonin, says a new study.

Guest Article

Ex-Health Canada NHP DG: ‘Cannabis is Canada’s New Wild West’

06-Jun-2023 By Adam Gibson, President, True Moderation

When it comes to regulating CBD and cannabis, Canada is an extreme cautionary tale for the US, says Adam Gibson, the former Director General of Health Canada’s Non-prescription and Natural Health Products Directorate.

CBD stakeholder’s call: “It’s really in Congress’ hands”

01-Jun-2023 By Danielle Masterson

With the ongoing theme of safety, FDA recently addressed CBD. While offering up several potential scenarios, the Agency said the CBD marketplace ultimately rests in the hands of Congress.

News

Extending the shelf-life of berries with CBD

19-May-2023 By Bethan Grylls

A team of researchers in Thailand have developed a CBD-based coating which has shown promise in delaying rot in strawberries to keep them fresher for longer.

Floyd Landis on the industry issue that keeps him on at night

11-Apr-2023 By Danielle Masterson

CBD sellers were holding onto hope that the FDA would regulate CBD in order to stabilize the industry and give customers confidence, but the lack of guidance has left business owners like Landis feeling trapped.

NutraCast: Payment processing challenges that nutraceutical merchants face

07-Apr-2023 By Danielle Masterson

Regulatory issues, high chargeback rates, reputation and fraud all make dietary supplements 'high-risk.' So when it comes to accepting online credit card payments, traditional financial institution don't want to go through the hassle.

DEA: Delta-8 and -9 THCO are controlled substances

02-Mar-2023 By Danielle Masterson

Once seen as a legal alternative to marijuana, the Agency is making it clear that synthetic cannabinoids are illegal under the Controlled Substances Act.

Study: CBD effective at reducing stress responses in dogs

28-Feb-2023 By Danielle Masterson

While many humans rely on CBD for stress and mood support, the effect it has on canines is not as well-documented. Now, scientists have research that shows how a single dose of CBD could benefit healthy dogs in two stress-inducing scenarios while deepening...

CBD brand fights inflation, regulatory limbo with price cuts

21-Feb-2023 By Danielle Masterson

Sunsoil is on a mission to make CBD be as accessible as Advil and Tylenol.

ADM on pet supplements: ‘Everything that is visible is a concern to a pet owner’

10-Feb-2023 By Stephen Daniells

Pet ownership soared during the pandemic and pet parents became attuned to the health of their canine and feline companions. Pet supplements will soon be a billion dollar category in the US, but there remains at least one exciting white space…

NutraWomen Wednesday: Inesa Ponomariovaite, Founder, Nesa's Hemp

08-Feb-2023 By Danielle Masterson

She may be a serial entrepreneur, humanitarian, health coach and the founder of a hemp company, but perhaps what makes Inesa Ponomariovaite stand out the most is her incredible story of survival.

Steve Mister on proposed FDA reorg, MPL, CBD, and CRN at 50

02-Feb-2023 By Stephen Daniells

The first month of 2023 is over, and already there’s some big developments (or non-developments in the case of CBD) for the US dietary supplements industry. We caught up with Steve Mister, president and CEO of the Council for Responsible Nutrition, to...

NPA's Fabricant on CBD, State-led regulations, and NMN's dangerous precedent

31-Jan-2023 By Stephen Daniells

2023 may be a New Year, but many of the old issues for the dietary supplements industry remain. In this wide-ranging interview with Daniel Fabricant, PhD, CEO of the Natural Products Association, we dug into some of the most front-of-mind issues for this...

More trades react to sleepy FDA

30-Jan-2023 By Danielle Masterson

“FDA’s indecision has been the decision on CBD for far too long”

Drumroll, please… waiting game continues to plague CBD industry

26-Jan-2023 By Danielle Masterson

Rumors about a big FDA announcement began swirling earlier this week, with the industry bracing for a potential end to a five-year wait on the regulatory future of CBD. But, much like the last few years, CBD professionals were left waiting without answers,...

Recover, reset, rebalance: formula addresses the 3Rs of adrenal health

24-Jan-2023 By Danielle Masterson

The new vegan offering by Vital Nutrients promises to bring the adrenal system back to life with next gen formula.

House Oversight chair to FDA: Enough is enough

17-Jan-2023 By Danielle Masterson

FDA’s failure to act on CBD created a space for bad actors and poor products to thrive, now the chairman—and the industry—want answers.

FDA to reveal CBD oversight plans soon

06-Jan-2023 By Danielle Masterson

After dragging its feet for nearly five years, the agency is gearing up to make big moves.

Guest Article: NPA Chief on 2022’s industry sagas and what these mean for 2023

20-Dec-2022 By Daniel Fabricant, PhD. President & CEO, the Natural Products Association (NPA)

As social creatures were often reluctant to pick sides. It feels personal that we’re picking one person or group of people over another. However, for our industry, the reality is that there are divisive issues.

‘A continuing pattern of antagonism by FDA toward CBD in food and beverages’: Experts weigh in on recent warning letters

05-Dec-2022 By Stephen Daniells

The recent raft of warning letters to brands selling CBD-infused foods and beverages marked a shift in FDA approaches to the ingredient, with the Agency seeming to opine that food and beverages are “somehow a greater risk than supplements”.

'Quite frankly, I'm concerned for our entire industry...' FDA cracks down on firms selling CBD-infused foods & beverages in ‘aggressive’ new stance

22-Nov-2022 By Elaine Watson

The FDA has sent out a raft of warning letters to brands selling CBD-infused foods and beverages, adopting an “aggressive position” that one industry source told us made him “concerned for our entire industry.”

Ashwagandha and apple cider vinegar sales surge as consumer spending on herbal supplements continues: ABC report

18-Nov-2022 By Stephen Daniells

US sales of herbal dietary ingredients grew by almost 10% in 2021 as the category exceeded $12.3 billion, according to the 2021 Herb Market Report from the American Botanical Council.

October Launch Pad

27-Oct-2022 By Danielle Masterson

Know your ABCs: Algae, bee propolis and CBD are a few standout ingredients that are out in full force this Fall.

NutraCast: How amendments in the 2023 Farm Bill could shape the hemp industry

13-Oct-2022 By Danielle Masterson

Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?

CBD entrepreneur Floyd Landis to share vision in upcoming NutraIngredients-USA webinar

10-Oct-2022 By Hank Schultz

Some CBD entrepreneurs talk a good game when it comes to their companies’ mission statements. Former pro cyclist Floyd Landis has lived his.

Upcoming webinar to examine tumultuous CBD market

28-Sep-2022 By Hank Schultz

Demand for CBD ingredients remains high and innovation continues apace even as the regulatory uncertainty of the category persists. A panel of influential speakers will delve into these and other questions in an upcoming webinar hosted by NutraIngredients-USA.

NextEvo launches Revive CBD Complex Curcumin and Hemp Extract

28-Sep-2022 By Asia Sherman

NextEvo Naturals has added Revive CBD Complex Curcumin and Hemp Extract to its line of water-soluble CBD products, formulated and clinically proven to maximize absorption.

Study: CBD has therapeutic potential for managing menopause

15-Sep-2022 By Danielle Masterson

The data offers preclinical evidence supporting further investigation of CBD as an option for post menopausal symptoms.

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...